Jeff Coller

Jeff Coller is a prominent scientist specializing in mRNA technology and a professor at Johns Hopkins University. He has been instrumental in advancing the understanding of mRNA's potential, particularly in the context of cancer treatment. Recently, he was in the news for his involvement in a groundbreaking study that found mRNA vaccines, initially designed for COVID-19, could significantly enhance the immune response in cancer patients, leading to improved survival rates. This research marks a pivotal moment in the development of therapies aimed at harnessing the body's immune system to combat various cancers.